67 related articles for article (PubMed ID: 7742604)
1. [EGF receptor, a prognostic factor in epidermoid cancers of the upper aerodigestive tracts].
Formento JL; Francoual M; Ramaioli A; Dassonville O; Santini J; Demard F; Schneider M; Milano G
Bull Cancer; 1994 Jul; 81(7):610-5. PubMed ID: 7742604
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
Dassonville O; Formento JL; Francoual M; Ramaioli A; Santini J; Schneider M; Demard F; Milano G
J Clin Oncol; 1993 Oct; 11(10):1873-8. PubMed ID: 8410112
[TBL] [Abstract][Full Text] [Related]
3. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
4. [Epidermal growth factor (EGF) receptors in squamous cell carcinoma of the head and neck region].
Lörz M; Bettinger R; Meyer-Breiting E
Laryngorhinootologie; 1991 Aug; 70(8):438-40. PubMed ID: 1910383
[TBL] [Abstract][Full Text] [Related]
5. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas.
Santini J; Formento JL; Francoual M; Milano G; Schneider M; Dassonville O; Demard F
Head Neck; 1991; 13(2):132-9. PubMed ID: 2022478
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of epidermal growth factor receptor in head and neck cancer: a meta-analysis.
Zhu X; Zhang F; Zhang W; He J; Zhao Y; Chen X
J Surg Oncol; 2013 Nov; 108(6):387-97. PubMed ID: 24038070
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
Stoehlmacher-Williams J; Obermann L; Ehninger G; Goekkurt E
Anticancer Res; 2012 Feb; 32(2):421-5. PubMed ID: 22287728
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced head and neck cancer: what lessons have we learned?
Conley BA
J Clin Oncol; 2006 Mar; 24(7):1023-5. PubMed ID: 16505419
[No Abstract] [Full Text] [Related]
11. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor (EGFR) as a prognostic marker: an immunohistochemical study on 315 consecutive breast carcinoma patients.
Aziz SA; Pervez S; Khan S; Kayani N; Rahbar MH
J Pak Med Assoc; 2002 Mar; 52(3):104-10. PubMed ID: 12071064
[TBL] [Abstract][Full Text] [Related]
13. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
15. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
16. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer.
Issing WJ; Liebich C; Wustrow TP; Ullrich A
Anticancer Res; 1996; 16(1):283-8. PubMed ID: 8615622
[TBL] [Abstract][Full Text] [Related]
18. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
[TBL] [Abstract][Full Text] [Related]
19. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.
Araki I; Washio M; Yamashita K; Hosoda K; Ema A; Mieno H; Moriya H; Katada N; Kikuchi S; Watanabe M
Surg Today; 2018 May; 48(5):478-485. PubMed ID: 29256147
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor mutation status and adjuvant chemotherapy in resected advanced non-small-cell lung cancer.
Sun HB; Ou W; Li Y; Fang Q; Qin J; Zhang L; Wang SY
Clin Lung Cancer; 2013 Jul; 14(4):376-82. PubMed ID: 23291256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
